Pacira | PCRX - Debt


Pacira reported $376.72M in Debt for its fiscal quarter ending in September of 2025.





Debt Change Date
Astellas Pharma JPY 831.43B 83.94B Mar/2025
Bristol-Myers Squibb USD 51.04B 112M Sep/2025
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 45.8B 4.97B Sep/2025
Ligand Pharmaceuticals USD 5.74M 5.72M Jun/2025
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Pacira USD 376.72M 203.77M Sep/2025
Perrigo USD 3.65B 454.7M Jun/2025
Pfizer USD 60.85B 78M Sep/2025
Supernus Pharmaceuticals USD 31.77M 531K Jun/2025
Teva Pharmaceutical Industries USD 17.07B 450M Sep/2025
Xeris Pharmaceuticals USD 257.65M 431K Sep/2025
Zoetis USD 6.79B 1.11B Jun/2025